moomoo ID:0
Log Out
  • English
  • 中文繁体
  • 中文简体

In-vitro Diagnostics Instruments Market to Record a CAGR of 7.95% | Technavio

PR Newswire ·  11/25/2021 17:10

NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The in-vitro diagnostics instruments market is expected to grow by USD 23.00 bn from 2020 to 2025, according to Technavio. The report offers an updated analysis of the present market scenario, the latest trends and drivers, and the overall market environment.

Fetch Free Sample Report to explore growth opportunities in the in-vitro diagnostics instruments market

Attractive Opportunities in In-vitro Diagnostics Instruments Market by Product, End user, and Geography - Forecast and Analysis 2021-2025

Top 3 In-vitro Diagnostics Instruments Market Players

  • Abbott Laboratories- The company offers in-vitro diagnostics instruments, namely Sapphire, Ruby, Emerald 22AL, and others.
  • Becton Dickinson and Co.- The company offers in-vitro diagnostics instruments for mycobacteria testing and identification and susceptibility systems.
  • Bio Rad Laboratories Inc.- The company offers in-vitro diagnostics instruments to screen microbial presence, grow and identify organisms, and test for antibiotic susceptibility.

Get lifetime access to our Technavio Insights. Subscribe now to our most popular "Lite Plan" billed annually at USD 3000. View 3 reports monthly and Download 3 Reports Annually!

In-vitro Diagnostics Instruments Market 2021-2025: Segmentation

  • Product
    • Immunochemistry
    • Clinical Microbiology
    • Molecular Diagnostics
    • Others
  • End-user
    • Hospitals And Diagnostic Laboratories
    • Academic And Research Institutes
    • Home Care
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

The in-vitro diagnostics instruments market is driven by the growing geriatric population, demand for personalized medicine, and product launches.

Download Our Free Sample for more information about market segmentation as well as the latest trends, drivers, and challenges

Reports that might interest you:

  • Surgical Instruments Market: The surgical instruments market has been segmented by product (surgical sutures and stapling devices, handheld surgical devices, and electrosurgical devices) and geography (North America, Asia, Europe, and ROW). Download Free Sample Report
  • Ventricular Assist Devices Market: The ventricular assist devices market has been segmented by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW). Download Free Sample Report 

In-vitro Diagnostics Instruments Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 7.95%

Market growth 2021-2025

USD 23.00 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 35%

Key consumer countries

US, China, Germany, Canada, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]

SOURCE Technavio

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites and Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.